Archives: Resources

Navigate the evolving landscape and leverage trends to overcome challenges, accelerate timelines and enhance efficiency.

Unlock the secrets to successful regulatory engagements for small biotech companies and equip your team with essential knowledge to navigate regulatory complexities and accelerate development timelines.

A new study by the Tufts Center for the Study of Drug Development reveals significant value in a fully integrated development model.

This white paper examines the key regulatory and ethical considerations for creating inclusive and representative clinical trial populations to improve the accuracy and relevance of research outcomes.

Learn more about the use of AI in drug development and clinical research processes.

Explore this report to understand evolving patient experience trends, recruitment challenges, and patient-first strategies for enhancing clinical trial success and confidence.

Our industry-leading experience includes clinical trials for the treatment of HIV, chronic hepatitis B and C, hepatitis D, RSV, influenza as well as various bacterial, fungal, and parasitic diseases.

This white paper explores the complexities of manufacturing, analysis, and regulatory requirements, offering insights into improving drug delivery, target specificity, stability, and compliance.

Experts discuss the latest trends and strategies in FSP partnerships, addressing drug development challenges and ensuring on-time, on-budget delivery.